News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
815 Results
Type
Article (33)
Company Profile (1)
Press Release (781)
Section
Business (233)
Career Advice (4)
Deals (55)
Drug Development (132)
FDA (20)
Job Trends (11)
News (432)
Policy (37)
Tag
Alliances (34)
Approvals (22)
Best Places to Work (6)
Biotechnology (1)
Cancer (1)
Career advice (4)
Clinical research (121)
COVID-19 (2)
C-suite (1)
Data (6)
Diagnostics (3)
Earnings (155)
Events (126)
Executive appointments (2)
FDA (28)
Funding (1)
GLP-1 (1)
Government (3)
Guidances (3)
Healthcare (7)
Infectious disease (3)
Interviews (1)
IPO (41)
Job creations (4)
Job search strategy (4)
Layoffs (1)
Legal (8)
Manufacturing (3)
Medical device (4)
Medtech (4)
Mergers & acquisitions (16)
NextGen: Class of 2026 (5)
Now hiring (1)
People (54)
Phase 1 (29)
Phase 2 (58)
Phase 3 (42)
Pipeline (10)
Postmarket research (1)
Preclinical (6)
Rare diseases (1)
Real estate (5)
Regulatory (36)
Research institute (3)
Resumes & cover letters (1)
Startups (1)
Vaccines (14)
Date
Last 30 days (1)
Last 365 days (54)
2026 (2)
2025 (58)
2024 (25)
2023 (29)
2022 (29)
2021 (40)
2020 (48)
2019 (79)
2018 (62)
2017 (56)
2016 (60)
2015 (40)
2014 (42)
2013 (61)
2012 (60)
2011 (42)
2010 (38)
Location
Asia (14)
Australia (1)
California (5)
Europe (53)
Nevada (1)
South America (1)
Southern California (3)
Texas (2)
United States (43)
Washington State (36)
815 Results for "omeros corporation.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Omeros Announces First Commercial Sales of YARTEMLEA®
January 28, 2026
·
8 min read
Rare diseases
Novo Offers up to $2.1B for Omeros’ Complement Drug To Expand Rare Disease Work
Novo Nordisk strikes another deal, this time with Omeros, amid a broader pipeline restructuring that recently claimed its cell therapy work.
October 15, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Omeros Announces New Date for YARTEMLEA® Approval Conference Call
December 29, 2025
·
7 min read
Press Releases
Omeros Corporation Announces Closing of Asset Purchase and License Agreement with Novo Nordisk for Omeros’ Clinical-Stage MASP-3 Inhibitor Zaltenibart (OMS906)
December 2, 2025
·
7 min read
Press Releases
FDA Approves Omeros’ YARTEMLEA® – First and Only Therapy Indicated for TA-TMA
December 25, 2025
·
17 min read
Press Releases
Omeros Corporation Reports Third Quarter 2025 Financial Results
November 14, 2025
·
20 min read
Press Releases
Omeros Corporation to Announce Third Quarter Financial Results on November 13, 2025
November 11, 2025
·
2 min read
Press Releases
Novo Nordisk and Omeros announce asset purchase and license agreement for Omeros’ clinical-stage MASP-3 inhibitor zaltenibart (OMS906)
October 16, 2025
·
8 min read
Press Releases
Omeros Corporation Reports Second Quarter 2025 Financial Results
August 15, 2025
·
20 min read
Press Releases
Omeros Corporation to Announce Second Quarter Financial Results on August 14, 2025
August 12, 2025
·
2 min read
1 of 82
Next
